Online Only Articles

Development of angiotensin II (1-7) analog as an oral therapeutic for the treatment of chemotherapy-induced myelosuppression

Department of Pharmacology, University of Arizona, Tucson, AZ;Center for Innovation in Brain Science, University of Arizona, Tucson, AZ
Titus Family Department of Clinical Pharmacy, School of Pharmacy, University of Southern California, Los Angeles, CA, USA
Department of Pharmacology, University of Arizona, Tucson, AZ;Center for Innovation in Brain Science, University of Arizona, Tucson, AZ
Titus Family Department of Clinical Pharmacy, School of Pharmacy, University of Southern California, Los Angeles, CA, USA
Department of Pharmacology, University of Arizona, Tucson, AZ;Center for Innovation in Brain Science, University of Arizona, Tucson, AZ
Vol. 103 No. 12 (2018): December, 2018 https://doi.org/10.3324/haematol.2018.193771